| PACKAGING TYPE: | 10x10 Blister (10 Strips In 1 Box) |
| COMPOSITION: | Repaglinide (0.5mg) + Voglibose (0.2mg) |
| FORMULATION: | Tablet |
| Description: | REPAMADE V 0.5/0.2 Tablet is a combination of Repaglinide 0.5 mg and Voglibose 0.2 mg. It is used for the management of type 2 diabetes mellitus, especially in patients requiring controlled postprandial (after-meal) blood glucose levels with a lower repaglinide dose. Repaglinide stimulates insulin secretion, while Voglibose delays carbohydrate absorption, providing effective dual-action glycemic control. |
| Side Effects: | Common: Hypoglycemia (low blood sugar) Flatulence Abdominal discomfort Diarrhea Serious (Rare): Severe hypoglycemia Liver function abnormalities Allergic reactions (rash, swelling, difficulty breathing) |
| How to Use: | Take as prescribed by a healthcare professional Usually taken before meals Swallow the tablet with water Follow dietary and lifestyle recommendations Regular blood glucose monitoring is advised |
| Precaution: | Monitor blood sugar levels regularly Use with caution in patients with liver or kidney disorders Avoid alcohol as it may increase risk of hypoglycemia Inform your doctor about all medications being taken Not recommended during pregnancy or breastfeeding unless prescribed |
| Product Benefits: | Helps control post-meal blood sugar spikes Dual mechanism improves glycemic control Suitable for patients requiring lower repaglinide dose Improves overall blood glucose stability Reduces risk of diabetes-related complications |
Frequently Asked Questions
It is used for type 2 diabetes mellitus to control post-meal blood sugar levels.
It is suitable for patients requiring mild to moderate glycemic control or dose titration.
Yes, under medical supervision with regular monitoring of blood glucose levels.













